Primary management of Hodgkin's disease.
D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000145:classification / Q000188:drug therapy / Q000532:radiotherapy*; D006801:Humans; D008207:Lymphatic Metastasis / Q000532:radiotherapy; D011879:Radiotherapy Dosage
D000477:Alkylating Agents; D000970:Antineoplastic Agents